Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A H Merrill

Showing results (141-150 of 150) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 150 results.
FEBS Letters|August 8, 1991
Functional differences in human neutrophils isolated pre- and post-prandiallyD J Uhlinger, D N Burnham, R E Mullins, et al.
Toxicology and Applied Pharmacology|January 1, 1997
Sphingolipids--the enigmatic lipid class: biochemistry, physiology, and pathophysiologyA H Merrill, E M Schmelz, D L Dillehay, et al.
The Journal of Biological Chemistry|July 21, 1998
Acylation of naturally occurring and synthetic 1-deoxysphinganines by ceramide synthase. Formation of N-palmitoyl-aminopentol produces a toxic metabolite of hydrolyzed fumonisin, AP1, and a new category of ceramide synthase inhibitorH U Humpf, E M Schmelz, F I Meredith, et al.
Biochemistry|April 18, 1989
Structural requirements for long-chain (sphingoid) base inhibition of protein kinase C in vitro and for the cellular effects of these compoundsA H Merrill, S Nimkar, D Menaldino, et al.
Plant Physiology|November 1, 1994
Fumonisin- and AAL-Toxin-Induced Disruption of Sphingolipid Metabolism with Accumulation of Free Sphingoid BasesH. K. Abbas, T. Tanaka, S. O. Duke, et al.
Toxicology and Applied Pharmacology|January 1, 1993
Alteration of tissue and serum sphinganine to sphingosine ratio: an early biomarker of exposure to fumonisin-containing feeds in pigsR T Riley, N H An, J L Showker, et al.
Environmental Health Perspectives|May 22, 2001
Sphingolipid perturbations as mechanisms for fumonisin carcinogenesisR T Riley, E Enongene, K A Voss, et al.
Cancer Causes & Control : CCC|November 21, 2001
Sphingolipids as biomarkers of fumonisin exposure and risk of esophageal squamous cell carcinoma in chinaC C Abnet, C B Borkowf, Y L Qiao, et al.
The Journal of Nutrition|October 5, 2001
A cross-sectional study of human serum sphingolipids, diet and physiologic parametersC C Abnet, C B Borkowf, Y L Qiao, et al.
Advances in Experimental Medicine and Biology|January 1, 1996
Fumonisin toxicity and sphingolipid biosynthesisA H Merrill, E Wang, T R Vales, et al.
Pageof 15

Showing results (141-150 of 150) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 150 results.
FEBS Letters|August 8, 1991
Functional differences in human neutrophils isolated pre- and post-prandiallyD J Uhlinger, D N Burnham, R E Mullins, et al.
Toxicology and Applied Pharmacology|January 1, 1997
Sphingolipids--the enigmatic lipid class: biochemistry, physiology, and pathophysiologyA H Merrill, E M Schmelz, D L Dillehay, et al.
The Journal of Biological Chemistry|July 21, 1998
Acylation of naturally occurring and synthetic 1-deoxysphinganines by ceramide synthase. Formation of N-palmitoyl-aminopentol produces a toxic metabolite of hydrolyzed fumonisin, AP1, and a new category of ceramide synthase inhibitorH U Humpf, E M Schmelz, F I Meredith, et al.
Biochemistry|April 18, 1989
Structural requirements for long-chain (sphingoid) base inhibition of protein kinase C in vitro and for the cellular effects of these compoundsA H Merrill, S Nimkar, D Menaldino, et al.
Plant Physiology|November 1, 1994
Fumonisin- and AAL-Toxin-Induced Disruption of Sphingolipid Metabolism with Accumulation of Free Sphingoid BasesH. K. Abbas, T. Tanaka, S. O. Duke, et al.
Toxicology and Applied Pharmacology|January 1, 1993
Alteration of tissue and serum sphinganine to sphingosine ratio: an early biomarker of exposure to fumonisin-containing feeds in pigsR T Riley, N H An, J L Showker, et al.
Environmental Health Perspectives|May 22, 2001
Sphingolipid perturbations as mechanisms for fumonisin carcinogenesisR T Riley, E Enongene, K A Voss, et al.
Cancer Causes & Control : CCC|November 21, 2001
Sphingolipids as biomarkers of fumonisin exposure and risk of esophageal squamous cell carcinoma in chinaC C Abnet, C B Borkowf, Y L Qiao, et al.
The Journal of Nutrition|October 5, 2001
A cross-sectional study of human serum sphingolipids, diet and physiologic parametersC C Abnet, C B Borkowf, Y L Qiao, et al.
Advances in Experimental Medicine and Biology|January 1, 1996
Fumonisin toxicity and sphingolipid biosynthesisA H Merrill, E Wang, T R Vales, et al.
Pageof 15